Home/Filings/4/0001823563-25-000007
4//SEC Filing

Chambers Rebecca 4

Accession 0001823563-25-000007

CIK 0001384101other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 7:44 PM ET

Size

8.6 KB

Accession

0001823563-25-000007

Insider Transaction Report

Form 4
Period: 2025-12-02
Chambers Rebecca
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-12-02$46.16/sh3,384$156,205122,774 total
  • Sale

    Common Stock

    2025-12-04$46.61/sh8,537$397,946114,237 total
  • Sale

    Common Stock

    2025-12-04$47.25/sh4,741$224,009109,496 total
Footnotes (4)
  • [F1]Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale.
  • [F2]The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $46.04 to $47.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]Represents weighted average sales price. Sale prices for the transactions range from $47.05 to $47.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001823563

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:44 PM ET
Size
8.6 KB